Posts

The brain processes speech and its echo separately

Echoes can make speech harder to understand, and tuning out echoes in an audio r...

First-ever atomic freeze-frame of liquid water

RICHLAND, Wash.—In an experiment akin to stop-motion photography, scientists hav...

Environmental monitoring offers low-cost tool for typho...

Researchers can accurately track where typhoid fever cases are highest by monito...

JNM outlines the future of theranostics in neurooncology

Reston, VA—Nuclear medicine has the potential to change the landscape of therano...

Three unexpected foods in alternatives to traditional p...

Future alternatives to fossil fuel-based plastics could be hiding in kitchen cab...

Researchers observe highly excited ‘roaming’ energy pat...

Scientists have observed so-called ‘roaming’ chemical reactions, those that at c...

Why do(n’t) people support being nudged towards healthi...

You may not realise it, but “nudge” has been used by businesses, policy-makers a...

GV1001 reduces neurodegeneration and prolongs lifespan ...

“[…] accelerated aging and Alzheimer’s disease are closely related, and this stu...

Covering all bases: Team publishes first-of-its-kind fi...

LOGAN, UTAH, USA — What’s black and white and red all over? It might be a velvet...

How Chinese migrants in Los Angeles Chinatown gained se...

In the late 1800s and early 1900s, anti-Chinese sentiment in the United States w...

CSL Behring’s major trial ends in disappointment After ...

CSL Behring, a prominent player in the Australian pharmaceutical landscape, rece...

Novo set to acquire Catalent plant for $16.5B

In November, regulators overseeing pharmaceutical standards in the U.S. identifi...

In an attempt to treat liver illness, Gilead buys CymaB...

Gilead Sciences has agreed to purchase CymaBay Therapeutics for $4.3 billion, ai...

Unlearn Secures $50 Million in latest funding round

Unlearn, a developer specializing in digital replicas, recently disclosed its at...

FDA grants fast track status to Edgewise’s Duchenne tre...

The US FDA has granted fast track designation to Edgewise Therapeutics’ EDG-5506...

BioAge secures $170m for obesity therapeutics development

BioAge Labs has secured $170m in an Series D funding round to progress the devel...